Imaging for early stage breast cancer

ELIOT: Confirmation trial 772 patients b/n 2006 and 2016 (Bergamo, Italy) Median F-up: 5.2 y. ASTRO classification

• Suitable

(n=116) : IBTR 1.2% (p<0.005)

• Cautionary (n=381) : IBTR 5.9%

• Unsuitable (n=275) : IBRT 13.5%

Takanen S et al, Breast Cancer Res Treat 2017